Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Thomas W. Frazier, Ph.D., is a Staff Member with Cleveland Clinic Children’s Hospital Center for Autism and Center for Pediatric Behavioral Health. He also is jointly appointed in the Genomic Medicine Institute and an Assistant Professor in the Lerner College of Medicine.
Dr. Frazier received his undergraduate degree Magna Cum Laude in psychology from John Carroll University in University Heights, Ohio, and completed both his master’s and doctoral degrees in clinical psychology at Case Western Reserve University. His post-graduate training includes an internship in clinical neuropsychology at Ann Arbor VA Medical Center and a fellowship in clinical neuropsychology at Cleveland Clinic’s Department of Psychiatry and Psychology, Section of Neuropsychology.
He has been an ad hoc reviewer for over 40 professional and peer-reviewed journals, and previously served as an associate editor for Assessment, a journal specializing in research on psychological assessment methods. Dr. Frazier is a member of the International Society for Autism Research.
Dr. Frazier has published more than 30 research articles in peer-reviewed journals , several invited articles and a book chapter, as well as having contributed more than 80 abstracts and presentations at national and international professional meetings. He has been an invited speaker at multiple local, national, and international professional organizations as well as local and national media outlets on topics concerning autism, pediatric bipolar disorder, ADHD, and on issues related to clinical assessment.
Over his short tenure, he has received awards from National Institute of Mental Health Career Development Institute for Bipolar Disorders to implement advanced statistical methods in the study of pediatric psychopathology and from the National Alliance for Research in Schizophrenia and Depression to study genetic and structural neural abnormalities in pediatric bipolar disorder. Most recently he received a National Institute of Health career development award (KL2) to train as a multidisciplinary clinical researcher studying the downstream effects of genetic changes leading to autism.
His primary clinical interest includes the assessment and behavioral treatment of individuals with autism spectrum disorder. However, Dr. Frazier also specializes in the assessment and differentiation of pediatric bipolar disorder, ADHD, and other disruptive behavior disorders in his clinical practice.
Appointed research director of the Center for Autism in 2009.
Awarded career development funding from the National Institute of Health in 2009.
Autism spectrum disorder, attention deficit hyperactivity disorder, pediatric bipolar disorder
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/5/2014, Dr. Frazier, II has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.